Hotaling Investment Management’s Halozyme HALO Stock Holding History

Hotaling Investment Management’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$250K	Buy	+4,398	New	+$225K	0.11%	101

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hotaling Investment Management's HALO Position: Q4 2022 in Review

Hotaling Investment Management opened a new position in Halozyme (HALO) in Q4 2022: 4,398 shares worth $250K. The stake represents 0.11% of the portfolio and ranks #101 among its holdings.

423 funds tracked by Wall St. Rank hold HALO as of Q4 2022.

Hotaling Investment Management held 4,398 shares of Halozyme worth $250K as of Q4 2022.
Halozyme was a new Hotaling Investment Management position in Q4 2022.
Halozyme made up 0.11% of Hotaling Investment Management's portfolio in Q4 2022, its #101 holding.
423 funds tracked by Wall St. Rank held Halozyme as of Q4 2022.

Based on Hotaling Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.